Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANTHEM, INC.

(ANTM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Anthem : Barclays Adjusts Anthem's Price Target to $450 From $425, Reiterates Overweight Rating

07/22/2021 | 08:03am EDT


ę MT Newswires 2021
All news about ANTHEM, INC.
09/23ANTHEM : Announces Appearance at Upcoming Conference
BU
09/16Hong Kong teachers exit under shadow of security law, schools scramble to fill gaps
RE
09/14Gynesonics Announces Anthem Issues Medical Necessity Coverage for the Treatment of Symp..
CI
09/09ANTHEM : Reaffirms 2021 Earnings Forecast
MT
09/09ANTHEM, INC. : Ex-dividend day for
FA
09/08ANTHEM, INC. : Regulation FD Disclosure (form 8-K)
AQ
09/08ANTHEM : Bernstein Adjusts Anthem's Price Target to $509 from $479, Keeps Outperform Ratin..
MT
09/02ANTHEM : CORRECTING and REPLACING Anthem Announces Appearance at Upcoming Conferences
BU
09/02Anthem, Inc. Launches Four-City Initiative with Heart of America and iHeartMedia to Com..
CI
08/31ANTHEM : Morgan Stanley Adjusts Anthem's Price Target to $468 From $459; Overweight Rating..
MT
More news
Analyst Recommendations on ANTHEM, INC.
More recommendations
Financials (USD)
Sales 2021 137 B - -
Net income 2021 6 123 M - -
Net Debt 2021 17 521 M - -
P/E ratio 2021 15,4x
Yield 2021 1,12%
Capitalization 92 974 M 92 974 M -
EV / Sales 2021 0,80x
EV / Sales 2022 0,72x
Nbr of Employees 83 400
Free-Float 99,4%
Chart ANTHEM, INC.
Duration : Period :
Anthem, Inc. Technical Analysis Chart | ANTM | US0367521038 | MarketScreener
Technical analysis trends ANTHEM, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Last Close Price 381,33 $
Average target price 434,91 $
Spread / Average Target 14,1%
EPS Revisions
Managers and Directors
Gail Koziara Boudreaux President, Chief Executive Officer & Director
John Edward Gallina Chief Financial Officer & Executive Vice President
Elizabeth E. Tallett Independent Chairman
Gloria M. McCarthy Chief Administrative Officer & Executive VP
Ramiro G. Peru Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ANTHEM, INC.18.44%92 974
UNITEDHEALTH GROUP16.35%383 843
CIGNA CORPORATION-2.75%69 345
HUMANA INC.-2.15%51 262
CENTENE CORPORATION4.65%36 627
MOLINA HEALTHCARE, INC.35.25%16 798